Shukri Abdallah Taha

Array ( [id] => 17790587 [patent_doc_number] => 20220249678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => PEGylated synthetic KL4 peptide, Compositions and Methods Thereof [patent_app_type] => utility [patent_app_number] => 17/625212 [patent_app_country] => US [patent_app_date] => 2020-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20798 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17990420 [patent_doc_number] => 20220356457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/624121 [patent_app_country] => US [patent_app_date] => 2020-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48781 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17868497 [patent_doc_number] => 20220291233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION [patent_app_type] => utility [patent_app_number] => 17/627953 [patent_app_country] => US [patent_app_date] => 2020-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20624 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18451548 [patent_doc_number] => 20230192826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => TAU EPITOPE AND BINDING MOLECULES [patent_app_type] => utility [patent_app_number] => 17/623577 [patent_app_country] => US [patent_app_date] => 2020-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26135 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18779122 [patent_doc_number] => 11820816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Anti-VEGF antibodies and methods of use [patent_app_type] => utility [patent_app_number] => 16/912950 [patent_app_country] => US [patent_app_date] => 2020-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24906 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17884055 [patent_doc_number] => 20220299532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => CORRECTING PROTEIN MISFOLDING IN DIABETES [patent_app_type] => utility [patent_app_number] => 17/618112 [patent_app_country] => US [patent_app_date] => 2020-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17844 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16507489 [patent_doc_number] => 20200386745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => PLACENTAL PROTEIN BIOMARKERS FOR GESTATIONAL AGE ASSESSMENT AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 16/893377 [patent_app_country] => US [patent_app_date] => 2020-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32084 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17721610 [patent_doc_number] => 20220214332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => Methods for Detecting A Mycobacterium Tuberculosis Infection [patent_app_type] => utility [patent_app_number] => 17/614271 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22402 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16435728 [patent_doc_number] => 20200353053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => RECOMBINANT FSH COMPOSITION FOR TREATMENT OF INFERTILITY [patent_app_type] => utility [patent_app_number] => 16/881163 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13813 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16539404 [patent_doc_number] => 20200405817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => IRS MODULATORS [patent_app_type] => utility [patent_app_number] => 16/876170 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16742083 [patent_doc_number] => 10967052 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-04-06 [patent_title] => Treatment of dyslexia using botulinum toxin [patent_app_type] => utility [patent_app_number] => 16/875912 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7449 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16755345 [patent_doc_number] => 10973873 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-04-13 [patent_title] => Treatment of asthma using botulinum toxin [patent_app_type] => utility [patent_app_number] => 16/875924 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6962 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16785012 [patent_doc_number] => 10987411 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-04-27 [patent_title] => Treatment of chronic obstructive pulmonary disease using botulinum toxin [patent_app_type] => utility [patent_app_number] => 16/875935 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5647 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16734440 [patent_doc_number] => 10960061 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-03-30 [patent_title] => Treatment of amyotrophic lateral sclerosis using botulinum toxin [patent_app_type] => utility [patent_app_number] => 16/875947 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6308 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17028573 [patent_doc_number] => 11090371 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-08-17 [patent_title] => Treatment of cirrhosis using botulinum toxin [patent_app_type] => utility [patent_app_number] => 16/875951 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7493 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16734439 [patent_doc_number] => 10960060 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-03-30 [patent_title] => Treatment of cardiac arrhythmia using botulinum toxin [patent_app_type] => utility [patent_app_number] => 16/875945 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7323 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16582889 [patent_doc_number] => 20210017291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF ATHEROSCLEROSIS [patent_app_type] => utility [patent_app_number] => 15/931976 [patent_app_country] => US [patent_app_date] => 2020-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16274 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17689377 [patent_doc_number] => 20220196670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => ENDOMETRIAL RECEPTIVITY DETERMINATION [patent_app_type] => utility [patent_app_number] => 17/611706 [patent_app_country] => US [patent_app_date] => 2020-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17762667 [patent_doc_number] => 20220236279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => Novel Selective ACKR3 Modulators and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/608427 [patent_app_country] => US [patent_app_date] => 2020-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17608427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17749665 [patent_doc_number] => 20220227869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => ASSOCIATION OF POLYCLONAL ANTIBODIES AND ANTI-PD1 OR ANTI-PDL1 ANTIBODIES FOR TH TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/607218 [patent_app_country] => US [patent_app_date] => 2020-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607218 [rel_patent_id] =>[rel_patent_doc_number] =>)